Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
27.00    1.00 (3.85%)
Bid:
26.00
Ask:
28.00
Spread: 2.00 (7.692%)
Market Cap: £12.86m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Trading Update

20 Jan 2022 07:00

RNS Number : 0240Z
Pennant International Group PLC
20 January 2022
 

 

FOR IMMEDIATE RELEASE 20 January 2022

PENNANT INTERNATIONAL GROUP PLC

Trading Update

 

 

Pennant International Group plc (AIM:PEN) ("Pennant", the "Group" or "Company"), a leading global provider of training technology and integrated product support solutions, issues the following trading update for the year ended 31 December 2021 ("FY21"). The Company expects to publish its full-year results during May 2022.

 

A preliminary unaudited assessment of the Group's trading for FY21 indicates:

 

· revenues of circa £16 million;

· loss before interest, taxation and amortisation of circa £0.6 million;

· net debt at year-end of £3.6 million;

· three-year order book at year-end of £22 million, of which £10 million is scheduled for delivery in 2022.

 

As expected, trading improved in the second half of FY21 (with the Group generating positive EBITA of circa £0.4 million for the period 1 July to 31 December) albeit the improvement was lower than budgeted as a result of two material factors, detailed below.

 

MTE Programme

 

The challenges associated with the MTE programme were previously highlighted in the Interim Results announcement of 22 September 2021 (and included supply chain issues, residual Covid impacts, global shortages and engineering complexity).

 

The build of the MTE devices is now largely complete, with customer acceptance testing having commenced in November 2021.

 

The testing process was temporarily paused before year-end, however, testing has now re-commenced, with two of the four training devices scheduled for delivery to site in February 2022.

 

The programme will, accordingly, be marginally extended; management anticipates that all devices will be delivered during the first half of 2022. Delivery of the devices will enable Pennant to invoice remaining cash milestones totalling circa £2 million.

 

In light of this extension, and to ensure the necessary resources to deliver and finally 'close off' this contract, the Board has prudently increased internal programme budgets (including a cost allowance to deal with any remaining risks) which is fully taken into account within the year-end position.

 

Contract award timing

 

Pipeline conversion in the second half of FY21 proceeded in line with the Group's expectations with one exception: a software and services contract with a new customer in the commercial aviation sector was slightly delayed. The contract had been expected to be awarded to Pennant before year-end but will now fall into the current year.

 

The contract is worth USD$1.1 million in the first year (and USD$1.8 million overall); the sale of software licences under the contract had been budgeted to contribute to the Group's performance for FY21. The terms of the contract have now been agreed and it is in the process of being finalised and signed.

 

Commenting on the Outlook for 2022, Pennant Group CEO, Phil Walker said:

 

"2021 was a challenging year for Pennant given the continued impact of the Covid-19 pandemic on our business sector and the wider global economy.

 

"It is therefore pleasing that momentum has started to build again in our core product offerings and pipeline of new business. The Group continues to focus on its strategic objective of increasing the proportion of revenues which derive from software and services which is intended to deliver significant growth over the medium-term.

 

"Bid activity is increasing across the Group, and the Board remains very confident of the award of the 'Major Programme' within the first quarter of the year.

 

"The Group remains well placed to capture the many opportunities which lie ahead and accordingly, the Board views prospects for 2022 with increasing confidence and looks forward to reporting a significantly improved performance for the current year."

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director

+44 (0) 1452 714 914

 

 

WH Ireland Limited (Nomad and Broker)

www.whirelandcb.com

Mike Coe

Sarah Mather

+44 (0) 20 7220 1666

 

 

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKCBDNBKBADD
Date   Source Headline
28th Mar 20117:00 amRNS2010 Final Results
22nd Mar 20117:00 amRNSRe Contract
4th Jan 20113:02 pmRNSChange of Registrars
8th Nov 201012:10 pmRNSDirectors incentivisation and Treasury Stock
5th Nov 20107:00 amRNSDirectorate Change
10th Sep 201012:24 pmRNSTransaction in Own Shares
9th Sep 20104:32 pmRNSHolding(s) in Company
6th Sep 20103:06 pmRNSTransaction in Own Shares
6th Sep 20107:00 amRNSHalf Yearly Report
14th Jul 201010:09 amRNSHolding(s) in Company
18th May 20101:01 pmRNSResult of AGM and GM
28th Apr 201011:10 amRNSHolding(s) in Company
13th Apr 20104:57 pmRNSPosting of Annual Report and Circular
29th Mar 20107:00 amRNSFinal Results
10th Mar 20107:00 amRNSSuccessful completion of Type 45 TMEC Warfare Pack
16th Feb 20107:00 amRNSNew Contract Award
11th Feb 201011:34 amRNSDividend Declaration (Replacement)
11th Feb 201010:32 amRNSDividend Declaration
11th Jan 20105:36 pmRNSTransaction in Own Shares
4th Jan 20102:25 pmRNSTransaction in Own Shares
17th Dec 200912:52 pmRNSDirector/PDMR Shareholding
1st Oct 200912:57 pmRNSIssue of Options and Option Amendments
9th Sep 200911:41 amRNSTransaction in Own Shares
7th Sep 20097:00 amRNSHalf Yearly Report
21st Jul 200912:27 pmRNSResult of AGM and GM
22nd Jun 20095:14 pmRNSAnnual Financial Report
15th Jun 20097:00 amRNS2008 Final Results
11th May 20097:00 amRNSNew Contract Award worth potential $CAN 15million
31st Mar 200911:55 amRNSHolding(s) in Company
29th Jan 20092:54 pmRNSHolding(s) in Company
29th Jan 20092:53 pmRNSHolding(s) in Company
31st Dec 20087:00 amRNSTotal Voting Rights
19th Dec 20083:05 pmRNSTransaction in Own Shares
24th Nov 20087:00 amRNSTrading Update
29th Sep 20087:00 amRNSInterim Results
11th Jul 20081:30 pmRNSHolding(s) in Company
13th May 20082:14 pmRNSResult of AGM and EGM
30th Apr 20084:30 pmRNSTotal Voting Rights
15th Apr 20087:00 amRNSDirector Dealings
11th Apr 200810:46 amRNSAnnual Report and Accounts
4th Apr 20087:00 amRNSFinal Results
7th Dec 200711:13 amRNSSale of Property
31st Oct 20074:30 pmRNSTotal Voting Rights
22nd Oct 200710:47 amRNSTransaction in Own Shares
18th Oct 200711:55 amRNSTransaction in Own Shares
4th Oct 20074:42 pmRNSTransaction in Own Shares
24th Sep 20077:00 amRNSInterim Results
17th Sep 20074:23 pmRNSSale of Property
17th Aug 20071:12 pmRNSAIM Rule 26 Information
2nd Jul 200710:56 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.